Zhejiang Huahai Pharmaceutical 483, Jul 2016

Zhejiang Huahai Pharmaceutical 483, Jul 2016

Peter Baker FDA$119.00

FDA investigators audited the Zhejiang Huahai Pharmaceutical facility in Taizhou, China and issued inspectional observations (via FDA 483) on 13 Jul 2016.

Buy This DocumentBuy 1-Year 483 Access

Product details

  • Inspection end: 13 Jul 2016
  • Location: Taizhou, China